text:
Cadence® system design and verification solutions, integrated under our Verification Suite, provide the simulation, acceleration, emulation, and management capabilities.
Verification Suite Related Products A-Z
Cadence® digital design and signoff solutions provide a fast path to design closure and better predictability, helping you meet your power, performance, and area (PPA) targets.
Full-Flow Digital Solution Related Products A-Z
Cadence® custom, analog, and RF design solutions can help you save time by automating many routine tasks, from block-level and mixed-signal simulation to routing and library characterization.
Overview Related Products A-Z
Driving efficiency and accuracy in advanced packaging, system planning, and multi-fabric interoperability, Cadence® package implementation products deliver the automation and accuracy.
Cadence® PCB design solutions enable shorter, more predictable design cycles with greater integration of component design and system-level simulation for a constraint-driven flow.
An open IP platform for you to customize your app-driven SoC design.
Comprehensive solutions and methodologies.
Helping you meet your broader business goals.
A global customer support infrastructure with around-the-clock help.
More Support Log In
24/7 Support - Cadence Online Support
Locate the latest software updates, service request, technical documentation, solutions and more in your personalized environment.
Visit Now
Software Downloads
Cadence offers various software services for download. This page describes our offerings, including the Allegro FREE Physical Viewer.
The Cadence Academic Network helps build strong relationships between academia and industry, and promotes the proliferation of leading-edge technologies and methodologies at universities renowned for their engineering and design excellence.
Participate in CDNLive
A huge knowledge exchange platform for academia to network with industry. We are looking for academic speakers to talk about their research to the industry attendees at the Academic Track at CDNLive EMEA and Silicon Valley.
Come & Meet Us @ Events
A huge knowledge exchange platform for academia. We are looking for academic speakers to talk about their research to industry attendees.
Americas University Software Program
Join the 250+ qualified Americas member universities who have already incorporated Cadence EDA software into their classrooms and academic research projects.
EMEA University Software Program
In EMEA, Cadence works with EUROPRACTICE to ensure cost-effective availability of our extensive electronic design automation (EDA) tools for non-commercial activities.
Apply Now For Jobs
If you are a recent college graduate or a student looking for internship. Visit our exclusive job search page for interns and recent college graduate jobs.
Cadence is a Great Place to do great work
Learn more about our internship program and visit our careers page to do meaningful work and make a great impact.
Get the most out of your investment in Cadence technologies through a wide range of training offerings.
Overview All Courses Asia Pacific EMEANorth America
Instructor-Led Training
Instructor-led training [ILT] are live classes that are offered in our state-of-the-art classrooms at our worldwide training centers, at your site, or as a Virtual classroom.
Read more
Online Training
Online Training is delivered over the web to let you proceed at your own pace, anytime and anywhere.
Exchange ideas, news, technical information, and best practices.
All Blogs
The community is open to everyone, and to provide the most value, we require participants to follow our Community Guidelines that facilitate a quality exchange of ideas and information.
All Forums
It's not all about the technology. Here we exchange ideas on the Cadence Academic Network and other subjects of general interest.
Cadence is a leading provider of system design tools, software, IP, and services.
I use ocean to run the corners analysys, i can save all the corner results,but can not gather the results together to plot family of waves.
Comparing to the corner or param analysys in ADE, i found i do not create a RUNOBJFILE to combine all the results.How to create such
a runobjfile or there are other methods instead? thanks.
that is my ocean script:
ocnWaveformTool( 'wavescan )simulator( 'spectre )design("/home/hlq/simulation/testbench_UX2018B/spectre/schematic/netlist/netlist")p=outfile("/home/hlq/ocean/result.txt" "w")cor1='("/home/hlq/tsmc/tmodel/ss.scs" "/home/hlq/tsmc/tmodel/ff.scs""/home/hlq/tsmc/tmodel/fs.scs""/home/hlq/tsmc/tmodel/sf.scs")tmp='(-40 85)vdd1='(2.97 3.63)foreach(cor2 cor1foreach(temp tmpforeach(vdd2 vdd1model=list(cor2 "")if(cor2=="/home/hlq/tsmc/tmodel/ss.scs" corn="ss")if(cor2=="/home/hlq/tsmc/tmodel/ff.scs" corn="ff")if(cor2=="/home/hlq/tsmc/tmodel/fs.scs" corn="fs")if(cor2=="/home/hlq/tsmc/tmodel/sf.scs" corn="sf")modelFile( model "")resultsDir(sprintf(nil "/home/hlq/ocean/%fV%dC%s" vdd2 temp corn ))analysis('ac ?start "1" ?stop "10G" )analysis('xf ?start "1" ?stop "10G" ?p "/outp" )analysis('noise ?start "1" ?stop "10G" ?p "/outp" ?n "/outn" ?oprobe "" ?iprobe "/I2" )analysis('dc ?saveOppoint t )desVar( "amp" 2u )desVar( "vdd" vdd2 )desVar( "cpink" 2.2n )desVar( "idd" 0 )option( 'temp "temp")
temp( temp )run()ICC = IDC("/V0/MINUS")GAIN = dB20(value(VF("/outp") 100000000))noise = abs((rmsNoise(1 940000000) / value((VF("/outp") - VF("/outn")) 100000000)))*1000000000bw = bandwidth((VF("/outp") - VF("/outn")) 3 "band")vpink = VDC("/net054")vin = VDC("/net21")vout = VDC("/net047")peaking = (ymax(dB20(clip(VF("/outn") 100000000 3e+09))) - dB20(value(VF("/outn") 100000000)))LC = bandwidth(clip(VF("/outp") 1 10000000) 3 "high")PSRR4M = value(db(getData("/V0" ?result "xf")) 4000000)fprintf(p, "%dC %fV %s %fA %fnA %fHZ %fdB %fHZ %fdB \n" temp vdd2 corn ICC noise bw peaking LC PSRR4M))))close(p)
I don't think there's a standard public function to do this. Worth contacting Customer Support as it's a worthwhile enhancement request. I may be wrong of course, and may have overlooked the existing of a function for this...
In reply to Andrew Beckett:
I would also like to do something similar. I even have a runObjFile but the simulations are only indexed by run number. I would have liked to add the swept variables as well so that I could plot the results versus one or the other swept variable. Unfortunately, I don't know the syntax to use for manipulating the runObjFile. My attempts at tinkering were not very useful. Any suggestions on adding parameters to the runObjFile would be welcome.
You can see an extract from the "doctored" version of my runObjFile, where I tried to add sweep variables "var1" and "var2".
TYPE"runObject" STRUCT("logName" ARRAY( * ) STRING *"parent" STRING *"sweepVariable" ARRAY( * ) STRING *) PROP( "key" "runObject" )VALUE"Root" "runObject" (("")""("run")("var1")("var2"))"../run000/psf" "runObject" (("../run000/psf/logFile")"Root"()) PROP("dataDir" "../run000" "run" 0 "var1" 0 "var2" 0.7)"../run001/psf" "runObject" (("../run001/psf/logFile")"Root"()) PROP("dataDir" "../run001" "run" 1"var1" 0"var2" 0.75)
In reply to vivkr:


text: Getty Images for AKOO Clothing [ T.I., 'Ball': Lil Wayne Shows Up on Rapper's New Orleans Bounce Record By Georgette Cline October 15, 2012 T.I. enlists the lyrical help of Lil Wayne on his new single, "Ball." The New Orleans bounce record will appear on Tip's forthcoming album, Trouble Man, due Dec... Read More Category: Hip-Hop Tags: Lil Wayne, lil wayne ball t.i., LilWayneBallT.i., T.I., t.i. ball, t.i. ball lil wayne, T.i.BallLilWayne EMAIL SHARE TWEET Pin it! REDDIT Share on Tumblr!

subset: commoncrawl


text:
Voting Rights Act brought big changesJun 27, 2013 By Connie Cass, The Associated Press
WASHINGTON -- The voting law that became a major turning point in black Americans' struggle for equal rights and political power is now outdated, the Supreme Court says.
Whether that's a marker of racial progress or proof of backsliding will be hotly debated. But neither side denies that remarkable changes were wrought through the nearly half-century-old Voting Rights Act.
As the issue moves to Congress, a look at the law's history:
15th Amendment
The right to vote, for American men at least, was supposed to be guaranteed when the 15th Amendment was added to the U.S. Constitution after the Civil War.
The amendment says: "The right of citizens of the United States to vote shall not be denied or abridged by the United States or by any state on account of race, color, or previous condition of servitude."
Freed slaves began voting and even winning office, but former Confederate states came up with tactics to evade the 15th Amendment.
These literacy tests, poll taxes and other discriminatory laws, as well as intimidation and violence, continued for decades. In 1940, only 3 percent of eligible blacks in the South were registered to vote, according to the American Civil Liberties Union.
Nearly a century after the amendment was ratified in 1870, the civil rights movement forced the nation to acknowledge the injustice.
The march from Selma
Activists who tried to help blacks register in the South in the 1960s were met with violence. The fatal shooting of a demonstrator by a law officer in Alabama inspired the idea of a march to the state capital on March 7, 1965.
Hundreds of marchers on their way to Montgomery were clubbed and tear-gassed by state troopers at the Edmund Pettus Bridge near Selma. TV news cameras captured what became known as "Bloody Sunday."
Protesters across the country rallied in support of the marchers. The Rev. Martin Luther King Jr. flew to Selma to lead demonstrations. And President Lyndon Johnson seized the momentum to propel the Voting Rights Act through Congress.
He signed it into law on Aug. 6, 1965.
Voting Rights Act
The law outlawed racial discrimination against voters in local, state and federal elections.
Some entire states, as well as counties in other states, were subjected to special federal enforcement, based on a formula used to weigh their record on voting rights. They had to get approval in advance before they could make even minor changes to voting laws, such as moving polling places.


text:
Get Buy Online Led Hula Hoops and Fire Hoops
Prism led hoops is the best dancing tool which can be used in LED hula hoops dance. Prism LED Hula Hoops are having some features which can make custom colour mixture in the form of slow-fading red-green-blue rainbow LEDs. All of our Led hula hoops and fire hoops are custom made according to your specification.
Chapter 1
Prism Led Hoops- A Best Dancing Tool
The Spinsterz is a leading LED Hoop company which provides different seven colours of LED hoops, Fire hoops, light weight LED hula hoops, Fire hoops at affordable prices. Get avail now high quality, low cost, and attractive LED hoops which be helpful to build the customized LED & Fire hoops during festivals, new years by kids and adult models during parties. Differ level of LED Technologies used to embed their processes in Video dancing tools like PRISM led Hoops, kaleidoscope-led-hoops which can be helpful to capture night time vision during parties. Occasion by fire dancers and adult models with use of LED's and Fire hoops.The Spinsterz are in business from last seven years and Get consistent positive feedback from our customers. To get any inquiry for products, performance and vending you can call us at 503-567-5282 or you can email us: email@example.com.


text:
Whole life insurance has been around for over 150 years. Universal life was introduced in the early 1980's. Universal Life offered the ability to increase or decrease the premium and death benefit and credited the cash values each year with a current interest rate. Variable life followed, which allowed policy owners to invest their cash values in equities. All three have their plusses and minuses.
Now there is a new kid on the block: Indexed Universal Life.
Here are the salient features:
1. Indexed Universal Life (IUL) is similar to Universal Life (UL); premiums and death benefits are flexible. You can increase or decrease premiums, or even stop them altogether. As your situation changes, you can decrease or increase (subject to insurability) the death benefit.
2. IUL is similar to Variable Life (VL) or Variable Universal Life (VUL) as the cash value is based on the increases of one or more stock indexes. The most common are the DJIA, NASDAQ 100 and the S & P 500.
Variable Life contracts allow direct investment in equities, much like a mutual fund. Indexed Universal Life policies do not invest directly in equities, so you do not have the same downside risk. The insurance company assumes all the risk.
If the index that you have chosen goes up over a given time frame (usually one year), your cash value goes up. However, if the index goes down, your cash value either stays the same or is credited with a minimum guaranteed interest rate, i.e. 2%.
3. How cool is that? If the market goes up, you get to participate in the growth. However, if the market goes down, your account doesn't go down; it stays the same. It gets even better. Any gains are locked in. They can never be taken away due to future decreases in the market. It's like walking up a flight of stairs. If the market goes up, you take a step up; if the market goes down, you stay where you are.
4. Indexed Universal Life has only been around for a few years. Only a few companies offer this contract. However, since 2000 the annual growth rate for this type of policy has been 24%.
When you speak with your life insurance agent about IUL, there are a few new terms you will need to understand:
1. Crediting Options
Crediting options are the math behind how the insurance company determines how much to credit your cash value at the end of each crediting period. The two most common are point to point and monthly average.
Point to point looks at the value of the stock index you chose at the beginning of each contract year and compares it to the value at the end of the point-to-point period. This is normally one year, but could be 2 or 5 years, depending on your contract choice.
Whatever happens in the interim doesn't matter. You could have a very high growth rate if the market and the corresponding index have a growth spurt during the last few months of the term. On the other hand, you could end up with a healthy loss if the index takes a dive during the latter part of your term with what to a regular investor would be a gain for the year.
The monthly average method takes a reading of the index each month. Then at the end of the year, adds them up and divides by twelve. This approach tends to smooth out the fluctuations.
Which one is better? It depends on your tolerance for risk and how the market performs during your policy's time frame. Since a life insurance policy is a long-term proposition, in the real world both should end up about the same over an extended period of time.
2. Participation Rate
Participation rate is the percentage of the increase in the index credited to your Indexed Universal Life policy each year. It could be, for example, 55%, 80%, 100% or 135%. Any given percentage rate is not necessarily better than another. It is simply the insurance companys way of factoring in their downside risk and is a component that allows you to negate a cash value decrease if the market goes down.
3. Cap Rate
The cap rate is the maximum rate of return the insurance company will credit to your policy each year. For example, if the cap rate is 12% and the index you chose went up 10%, your policy is credited with a 10% gain. However, if the index increased 15%, your policy is credited with 12%, the cap. Not all Indexed Universal Life contracts have a cap. Participation rates and cap rates work in conjunction with each other.
Indexed Universal Life is an exciting new approach. If you are looking for a rate of return that is higher than traditional whole life or universal life, but don't want the market risk of variable life, indexed universal life may be for you. The fact that the cash values are based on the performance of the equity market, coupled with the feature that prevents loses and locks in gains should be enough to warrant further exploration.
Robert D. Cavanaugh, CLU is a 36-year financial and estate planning veteran and author of the free newsletter, "The Estate Preservation Advisor". For cutting-edge, easy-to-understand financial planning resources and techniques to increase your income, reduce taxes and preserve your estate and to claim the free video, "How to Sell Your Life Insurance Policy for More than the Cash Value", go to http://theestatepreservationadvisor.com/rd/subscribe.htm


text:
follow the instructions of kincaellan, i am [email protected] , he does them with isomalt, because this kind of sugar is always white or transparent.never burn and turn yellow itself. follow all what he told me ..... i have wrote TO KINCAELLAN, or KINCAELLAN, these answers are in this page. good luck.
0 replies


text:
Last week I held an interview with a ROTH Capital senior analyst, who recommended Delcath Systems (NASDAQ:DCTH) as a buy and reiterated a one-year price target of $6 a share, representing a premium of 228% to DCTH stock closing price of $1.83. Since the publication of the interview, investors have shown a strong vote of confidence in the company's prospects, and the share price has risen nearly 12%.
The company is currently waiting for the FDA acceptance of its New Drug Application (NDA) for CHEMOSAT, the company's proprietary hepatic chemosaturation system for the treatment of unresectable metastatic cutaneous and ocular melanomas of the liver. Delcath requested a priority review (6 months) for CHEMOSAT when the NDA was resubmitted. By regulation, the Food and Drug Administration (FDA) will notify the company of a priority review in writing by day-60, or of a standard review (10 months) by day-74. Since the NDA resubmission announced on August 15, 2012, Day 60 would be October 14 and Day 74 would be October 28.
This week, as part of my research, I've had the honor of interviewing Mr. Eamonn P. Hobbs, President and Chief Executive Officer of Delcath Systems. Mr. Hobbs was appointed President and Chief Executive Officer of Delcath in July 2009 and has been a director of Delcath since October 2008. He has over 30 years of experience in the interventional radiology, interventional cardiology, and gastroenterology medical device industries. From 1988 until 2009, Mr. Hobbs was co-founder, President and Chief Executive Officer of AngioDynamics (NASDAQ:ANGO), which he built into a leading medical technology company with an international market presence and a highly diverse product line. He left a very comfortable position to take Delcath through the FDA process and into commercialization. Mr. Hobbs is currently Chairman of the Medical Device Manufacturers Association, serves on the Board of Directors of Antares Pharma (NASDAQ:ATRS), and is a member of that Board's audit committee. In 2009, Mr. Hobbs also joined the Board of Directors of Cappella Cardiovascular Innovations, Inc. and was elected Chairman of the Board in 2010
Ben Yoffe: Mr. Hobbs, in February 2011, Delcath received a "refusal to file" letter from the FDA for the New Drug Application (NDA) of the Company's proprietary system for chemosaturation therapy (CHEMOSAT). Can you provide us more details about the amendment and the amendment process regarding the NDA resubmission?
Hobbs: The FDA's "refusal to file" letter requested information involving manufacturing plant inspection timing, product and sterilization validations and additional safety information as well as additional statistical analysis clarification. To address the issues the FDA identified in their letter, we began very substantive work on clinical and safety data gathering from all of the clinical sites and migration to FDA compliant clinical and safety databases. This included migration of clinical data for the Phase I, II and III studies from the database used at the NCI to a CDISC compliant database that allows us to provide data to the FDA in a more "FDA review friendly" manner. We also created the Company's first safety database, which includes a pharmacovigilance and medical device database, and implemented a significantly expanded Case Report Form that allowed capture of far more comprehensive and detailed data points related to the RTF, such as Severe Adverse Events (SAEs), hospitalization, concomitant medications, all labs and procedure related data, all of which conservatively represents the addition of over 1.4 million new data points to the new database which was presented to FDA in our NDA submission. We also supported the hire of additional data entry staff at the clinical sites to aid with data entry, and hired clinical research audit experts to improve our GCP audit readiness. Delcath has engaged in ongoing communications with the FDA and, following on a pre-NDA meeting in mid-January of this year, we believe we've resolved all outstanding safety queries.
We requested priority review for our NDA at the time of filing and, assuming the NDA is accepted and that priority review is granted, our expected PDUFA date would be in February of next year. We believe that our application meets the FDA's criteria for priority review based upon the strength of our clinical trial data, along with the limited treatment options available for patients with unresectable melanoma metastases in the liver
Yoffe: The company included its Generation 2 filter in its NDA submission. However, it was submitted without any efficacy or safety data from clinical trials. Can you shed some light on this issue?
Hobbs: Our NDA is based upon the efficacy and safety data generated from the use of the Generation 1 system in our clinical trials. At the same time, after consultation with a variety of experts and the FDA, we have agreed to include the addition of the Generation 2 filter in the NDA as a technical change as part of the CMC or Chemistry, Manufacturing and Control module. We believe it is in the best interest of U.S. patients to accelerate availability of Generation 2 and that, if approved, this approach represents the fastest regulatory review path for the Generation 2 system.
Yoffe: Can you give us a picture of the market size for CHEMOSAT in the U.S?
Hobbs: We believe the potential market opportunity for melanoma liver metastases indication we are seeking is approximately $500 million. In the future, we hope to include indications in colorectal cancer metastases, hepatocellular carcinoma, and neuroendocrine tumor metastases, and we believe the market opportunity in the United States with these additional indications is approximately $2.6 billion.
Yoffe: What can you tell us about the competition?
Hobbs: There are many treatment approaches for cancers in the liver, each with its own advantages and disadvantages. For patients with unresectable melanoma metastases in the liver, current treatment options are limited. Systemic chemotherapies are non-invasive and repeatable but are associated with systemic toxicities and limited efficacy in the liver. Regional treatments like Isolated Hepatic Perfusion, which is an open surgical procedure that temporarily separates the liver's blood supply from blood circulating throughout the rest of the body and allows high doses of anticancer drugs to be directed to the liver only, are highly invasive and have a limited repeatability. Focal treatments such as surgical resection, radio-embolization, chemoembolization, and radio-frequency ablation to remove or treat individual liver tumors are limited to lesions visible on medical imaging and by their size, number, and location within the liver. Only 10-20 percent of tumors are treatable by this approach.
In hepatic chemosaturation therapy, a percutaneous hepatic perfusion (PHP) procedure delivers ultra- high doses of intra-arterial chemotherapy directly into the isolated liver, saturating both the liver and the tumor cells. The blood from the liver is drained through an isolation-aspiration catheter, and then directed outside the body to proprietary filters, which reduce the concentration of chemotherapeutic agent before this blood is returned to the body.
The potential of chemosaturation therapy includes:
The ability to administer higher doses of chemotherapeutic agent to the liver than could be delivered with traditional systemic-intravenous methods
Significant reduction of systemic exposure to the higher dose levels
It is worth noting that some of the physicians in the U.S. and Europe who have used chemosaturation therapy have already stated that they see a potential complementary role for therapy with other treatments, and believe that the therapy may have a role to play as part of an overall disease management approach. This potential obviously must be validated through actual clinical practice, but these comments suggest that physicians familiar with the therapy do not view it as competitive to existing treatments, but as a possible bridge to them.
Yoffe: What are your commercialization plans for CHEMOSAT in the U.S?
Hobbs: We intend to commercialize our chemosaturation system ourselves in the U.S., with an initial focus on Interventional Radiologists and Surgeons at leading cancer centers and referring community hospitals, using a dedicated medical science liaison team to educated Medical Oncologists throughout the referring network. We intend to utilize top centers that participated in our Phase III trial as Centers of Excellence for training and support. We will seek chemosaturation specific codes based on a value proposition relative to other cancer therapies.
Yoffe: Can you tell us about your expectations regarding the ongoing commercial launch of CHEMOSAT in Europe?
Hobbs: The bulk of the year is being spent on laying the foundation of training, reimbursement, patient recruitment and education of the referral network. In the first half of this year, we exceeded our initial goal of signing 6 to 8 European cancer treatment and research centers through initial launch and training agreements. We signed a total of 13 such centers to date and have a presence in all seven of our target markets of Italy, Germany, France, the United Kingdom, Spain, the Netherlands and Ireland. Five of these centers, each in a different country, have begun treating patients so far. With agreements in our target markets in place, our priority for the rest of the year is to complete the training process at each center and drive clinical adoption of their therapy in respective referring networks.
We received CE Mark approval for the Generation 2 CHEMOSAT system in April, and the first Gen 2 case was performed at the European Institute of Oncology that same month. On the investor call we held
August 7, we reported that a total of 16 procedures have been completed in Europe on 13 patients with liver dominant metastasis from cutaneous and ocular melanoma, gastric cancer, breast cancer and cholangiocarcinoma. Going forward, we do not intend to provide regular updates on procedure volumes, and will limit any additional commentary to appropriate public opportunities.
Since our agreements with initial launch centers include an initial small supply of sample kits free of charge, we expect that revenue will be realized more weighted toward 2013, sales driven primarily by the activated centers we have so for and by our third-party distributors.
Yoffe: Do you have plans to market CHEMOSAT in the rest of the world?
Hobbs: In the Asia-Pacific, we expect to have two CHEMOSAT centers in Australia and one in Hong Kong by the end of this year. In Australia, where CHEMOSAT is approved, we are marketing this system directly on an interim basis, while we search for a suitable distributor to drive clinical adoption.
In Argentina, we have selected a distributor, who is in the process of submitting the application to register the CHEMOSAT system, which would cover requirements in Chile as well, with approvals expected in 2013. We are targeting specific centers in these markets with affiliations with major US cancer hospitals, which will provide an avenue for international patients from countries where CHEMOSAT is currently unavailable as a treatment option.
We currently expect regulatory approval of Gen 2 in Canada by the end of this year, Singapore in 2013, and Brazil in 2014.
Yoffe: Are there any other significant products in Delcath's clinical-stage pipeline?
Hobbs: We continue to move forward with the development of a CHEMOSAT system for use with doxorubicin, a chemotherapeutic agent shown to be effective in the treatment of HCC or primary liver cancer. We expect to be able to apply for the CE Mark for CHEMOSAT with doxorubicin this Fall. The CE Mark for CHEMOSAT with doxorubicin would assist in initiating clinical trials in the treatment of HCC in China and Taiwan, which we believe are the primary markets for CHEMOSAT with doxorubicin.
Also on the R&D front, we have initiated two R&D programs to evaluate a variety of chemotherapeutic agents for use in new CHEMOSAT systems to treat cancers of the lung and brain. These programs involve the development of dedicated isolation catheter systems, unique filters, and procedural changes associated with treating the lung and brain, which have some unique challenges compared to the liver.
Yoffe: To close, is Delcath funded well enough to get through all of the upcoming steps or will the company be looking for additional funding?
Hobbs: Our last quarterly report was for the period ended June 30, 2012. At that time, our cash balance was approximately $29.3 million. As of June 30th, we remained debt-free and have a $20 million working capital credit facility with Silicon Valley Bank that provides us with additional financing options to access capital to support our commercialization plans, if needed. In addition, our Board of Directors and our management team are constantly evaluating ways to strengthen our balance sheet while at the same time maximizing returns to our shareholders.
Disclosure: I am long DCTH. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.


text:
Rays Race Back To Even After Falling 18-games Under
By defeating the New York Yankees by a final score of 5-0 the Tampa Bay Rays (61-61) evened their record for the first time since April 22nd when they were 10-10.They become just the fourth team joining the t 2004 Devil Rays, the 2006 Florida Marlins, and the 1899 Louisville Colonels as the only teams in major league history to fall to 18 games under .500 in a season and rebound to .500.
The road back from 18 games below .500 on June 11th has been difficult. "It was not easy. We definitely dug ourselves a substantial hole and then we're getting out of it now." Joe Maddon said. "To get back to even ground is very important in that we can look forward. It's still about winning series."
The victory pulled the Rays within nine games of the AL East leading Baltimore Orioles who fell to the Cleveland Indians and they move to 5.5 games behind the Seattle Mariners who took over the second Wild Card spot by defeating the Detroit Tigers.
Alex Cobb (8-6, 3.41 ERA) won his second home start on the year and second in as many outings leading the Tampa Bay Rays past the New York Yankees in the first game of their three game series.
He was removed after throwing 112 pitches (71 for strikes) delivering 7.1-innings of scoreless ball allowing six hits (all singles) striking out eight and walking one. He was able to record 10 outs on nine ground balls and was able to generate 15 swing and misses from the Yankees hitters
Cobb improves to 5-1 with a 1.75 ERA (11ER/56.2IP) in eight career starts against the Yankees. The victory was his sixth win in a row matching a career high and tying David Price for the longest winning streak for the Rays this season.
Most impressive is the fact that Cobb has delivered seven consecutive starts of two earned runs or less tying the franchise record set by Matt Moore (twice) and Victor Zambrano.
He was not happy to depart in the eighth inning but since his pitch count was the second most in his career (117 September 21, 2013) Maddon was not taking any chances. After retiring the leadoff hitter in the eighth inning he allowed a single to Francisco Cervelli and then walked Brett Gardner.
Brad Boxberger came in and allowed a sharp single to right to load the bases. The Yankees were not able to capitalize on the threat as Jacoby Ellsbury and Mark Teixiera both struck out to end the inning. Joel Peralta came in to work the ninth inning to end the ballgame.
The Rays kicked the scoring off in the bottom of the first inning off Brandon McCarthy (7-12, 4,24 ERA). In the bottom of the first the Rays loaded the bases with nobody out against Yankees starter Brandon McCarthy and Evan Longoria and James Loney each hit groundballs to the infield to score Desmond Jennings and Ben Zobrist to give the Rays a 2-0 lead.
He kept the Rays off the board until the bottom of the seventh inning when Logan Forsythe reached on a Chase Headley error and moved into scoring position on a 2-strike sacrifice bunt by Yunel Escobar. Curt Casali delivered an opposite field RBI single to score Forsythe and extend the Rays lead to 3-0.
The Rays proceeded to get shallow fly ball singles off the bat of Kevin Kiermaier and Desmond Jennings to load the bases for Ben Zobrist. He would not get to face McCarthy as Joe Girardi went to his bullpen and summoned Esmil Rogers.
Zobrist sent a ground ball that deflected off Mark Teixeira to second baseman Stephen Drew who threw Zobrist out at first but Casali came across to score putting the Rays up 4-0.
On the evening McCarthy was charged with four runs (two earned) in 6.1 innings of work on seven hits striking out seven and walking one.
The Yankees loaded the bases in the top of the eighth inning but Brad Boxberger struck out Jacoby Ellsbury and Mark Teixiera to end the inning.
James Loney delivered a solo home run to lead off the ninth inning to put the Rays ahead 5-0. It was Loney's 6th home run of the season and first since July 1st against the Yankees Hiroki Kuroda.
Joel Peralta came in to end the game and return the Rays to .500.
The Rays will look to continue their winning ways as Drew Smyly (7-10, 3.73 ERA) takes on Shane Greene (3-1, 2.89 ERA) tomorrow at 4:10 pm.


text:
Lynchburg College Takes Part in Day of Service
Lynchburg, VA - First year students at Lynchburg College took part in a day of service Wednesday.
We caught up with some of the students Wednesday morning at the Lynchburg Daily Bread.
Some 530 students spanned the city volunteering at eight non-profit organizations Wednesday morning.
They went to seven more locations Wednesday afternoon.
Those participating say they enjoy the opportunity to give back to the community where they plan to spend the next four years of their college career.
"I think it's good to give back to the Greater Lynchburg community, you know it just give me something else to do off campus and I just feel better, since I'm not from here just giving back to a town that I'm not from," said Steele Clay, a Freshman at Lynchburg College.
This has become an annual event at Lynchburg College.


text:
Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
|Unresectable Locally Advanced NSCLC
|Drug: Cisplatin; Etoposide; Radiation therapy; Docetaxel; Neulasta
|Phase 2
|Study Type:
|Study Design:
|Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
|Official Title:
|Phase II Trial of Combined Modality Therapy With Growth Factor Support in Locally Advanced NSCLC
- To determine the safety and efficacy of administering pegfilgrastim with concurrent chemoradiotherapy and the potential benefit of administering pegfilgramstim with consolidation chemotherapy in patients with unresectable locally advanced NSCLC patients. [ Time Frame: One year ]
- To determine the frequency of dose reductions, dose delays, and dose omissions during chemoradiotherapy with filgrastim and consolidation therapy with pegfilgrastim. [ Time Frame: One year ]
|Study Start Date:
|September 2003
|Study Completion Date:
|January 2010
|Primary Completion Date:
|January 2010 (Final data collection date for primary outcome measure)
|Assigned Interventions
Cisplatin 75 mg/m2 day 1 and 22
Etoposide 80mg/m2 days 1-3, 22-24
Radiation therapy: (initial fields 1.8gy/day (5 weeks) to 45Gy, then boost 2.0Gy/day (8 days) to a total of 61Gy) beginning day 1 (Total elapsed time: approximately 6 weeks, 3 days)
Filgrastim 5µg/kg* SQ injection days 4-13 and days 25-34
Docetaxel 75mg/m2 Q 3 Weeks X 3 Cycles
Pegfilgrastim 6 mg SQ injection day 2 of each cycle
Drug: Cisplatin; Etoposide; Radiation therapy; Docetaxel; Neulasta
Cisplatin 75 mg/m2 day 1 and 22
Etoposide 80mg/m2 days 1-3, 22-24
Radiation therapy: (initial fields 1.8gy/day (5 weeks) to 45Gy, then boost 2.0Gy/day (8 days) to a total of 61Gy) beginning day 1 (Total elapsed time: approximately 6 weeks, 3 days)
Filgrastim 5µg/kg* SQ injection days 4-13 and days 25-34
Docetaxel 75mg/m2 Q 3 Weeks X 3 Cycles
Pegfilgrastim 6 mg SQ injection day 2 of each cycle
|Ages Eligible for Study:
|18 Years to 90 Years (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria:
- Histologically or cytologically confirmed NSCLC: Either histologic or cytologic proof of a newly diagnosed non-small cell lung cancer is required. A biopsy with histology is preferred, but cytology is allowed. Histology or cytology from involved mediastinal or supraclavicular lymph nodes alone will be allowed if a separate distal primary lesion is clearly evident on radiographs (i.e., a second biopsy will not be required).
- Patients with two or more parenchymal lesions on same or opposite sides of the lung are ineligible.
- Must have unresectable Stage IIIA (N2) or IIIB disease and also satisfy the following criteria:
Unresectable Stage IIIA (N2) patients:
- N2 mediastinal lymph nodes must be multiple and/or bulky on CT scan or X-ray, such that, in the opinion of the treating investigator, the patient is not a candidate for induction chemotherapy or chemoradiotherapy followed by surgical resection.
- N2 status must be documented by any one of the following methods:
- Histologic or cytologic proof of N2 disease by exploratory thoracotomy, thoracoscopy, mediastinoscopy, mediastinotomy, Wang needle biopsy, fine needle aspiration under bronchoscopic or CT guidance or other method
- Node positivity by PET scan
- Nodes >2 cm on CT scan
- Paralyzed left true vocal cord with separate left lung primary distinct from AP window nodes on CT Scan
- Stage IIIB patients:
- Pathologic documented or radiographically documented positive N3 nodes.
Patients with positive supraclavicular or scalene lymph nodes must not have disease extending up into the cervical region evidenced by one of the following:
- Fine needle aspiration, core needle biopsy or excisional biopsy of supraclavicular N3 nodes
- Biopsy of contralateral mediastinal N3 nodes by mediastinoscopy, mediastinotomy, or thoracotomy
- Fine needle aspiration, core needle or Wang needle biopsy under CT or bronchoscopic fluoroscopic guidance of enlarged contralateral N3 mediastinal nodes
- Contralateral mediastinal nodes >2 cm on CT scan
- Contralateral node positivity on PET scan
- Right sided primary with paralyzed left true vocal cord
Any of the following T4 lesions: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body or carina:
- Written documentation of type of T4 extent by attending surgeon if the patient has had an exploratory thoracotomy or thoracoscopy
- T4 involvement of the trachea or carina by direct bronchoscopic visualization
- T4 involvement of the heart, esophagus, aorta, or vertebral body documented by CT scan, MRI or transesophageal ultrasound
- T4 involvement of the mediastinum may also be accepted by CT or MRI criteria if, in absence of the above organ involvement, there is a soft tissue extension directly into the mediastinal space.
- Radiographic criteria for involvement of main pulmonary artery or vein is allowed only if there is a mediastinal soft tissue mass.
- Age > 18 years
- ECOG performance status 0 or 1
- Ability to give informed consent
Adequate organ and marrow function as evidenced by the following peripheral blood counts or serum chemistries at study entry:
- WBC > 4,000/µL
- Absolute neutrophil count > 1,500/mm3
- Platelet count > 100 x 103 cells/mm3
- Bilirubin < 1.5 x institutional ULN
- AST or ALT < 2.5 x institutional ULN
- Alkaline Phosphatase <2.5 x institutional ULN
- Serum Creatinine < 2.0mg/dL and/or adequate creatinine clearance
- Adequate pulmonary function (FEV>1.5 liters, or if <1.5 liters, the predicted FEV1of the contralateral lung must be >800 cc based on the quantitative split function testing. (Predicted FEV1= FEV1 x % perfusion to uninvolved lung from quantitative lung V/Q scan report)
- Must have one measurable lesion by chest X-ray or CT scan. Lesion(s) must be accurately measured in at least one dimension (longest diameter to be recorded) as >20mm with conventional techniques or as >10mm with spiral CT scan
- Men and women of childbearing potential must agree to use effective contraception while on treatment and for 6 months after treatment
Exclusion Criteria:
- Malignant pleural or pericardial effusion
- Prior chemotherapy or radiation therapy
- Pregnant or lactating females
- Primary malignancy other than basal or squamous carcinoma of the skin or carcinoma in situ of the cervix, or any other cancer for which the patient has been disease free for five years. Other in situ malignancies (e.g. breast, bladder, etc) in the past 3 years are permissible
- Unintentional weight loss >10% body weight within the last 3 months
- Unable to provide informed consent
- Any pre-malignant myeloid condition or any malignancy with myeloid characteristics
- Active infection
- Known hypersensitivity to E. coli-derived proteins, pegfilgrastim, Filgrastim, or any other component of the product
- Significant nonmalignant disease including: documented HIV infection; uncontrolled heart disease, and poorly controlled diabetes
- Treatment within the last 30 days with any experimental agent
Please refer to this study by its ClinicalTrials.gov identifier: NCT00682383
|United States, Florida
|Mount Sinai Medical Center
|Miami Beach, Florida, United States, 33140
|Principal Investigator:
|Rogerio Lilenbaum, MD
|Icahn School of Medicine at Mount Sinai
|Responsible Party:
|Rogerio Lilenbaum, M.D., Principal Investigator Rogerio Lilenbaum, M.D., Mt. Sinai Medical Center, Miami
|ClinicalTrials.gov Identifier:
|NCT00682383 History of Changes
|Other Study ID Numbers:
|Study First Received:
|May 20, 2008
|Last Updated:
|October 29, 2012
Keywords provided by Rogerio Lilenbaum, M.D., Mt. Sinai Medical Center, Miami:
Advanced NSCLC
Lung Cancer
Mount Sinai Medical Center CCOP
Additional relevant MeSH terms:
Etoposide phosphate
Antineoplastic Agents
Tubulin Modulators
Antimitotic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents, Phytogenic
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
ClinicalTrials.gov processed this record on September 21, 2017


text:
17232 E Second Street, Wellston 49689
See more homes for sale in Wellston, MI
This well-built year around home is located on a county maintained road in the Village of Wellston. There are 2 bedrooms, 1 bath, large open living room with a brick wall mantel and hearth for the wood stove, the kitchen has lots of hardwood cupboards and a large dining area. The entry way has lots of storage. There is a large utility room right off the kitchen with floor to ceiling storage and access to the one car attached garage. You can walk to Little Crystal Lake which has a sandy beach area and T dock to enjoy the summer. It's also a pretty good little fishing lake. The post office, library, community center and fire department are just around the corner! Perfect retirement or starter home! The home should qualify for low down financing!
Property Information
- Status
- Contingency [?]
- Address
- 17232 E Second Street
- City
- Wellston
- Zip
- 49689
- County
- Manistee
- Township
- Norman Twp
- Total Finished SqFt
- 1,600
- Above Grade SqFt
- 1,600
- Garage
- 1.0
- Garage Desc.
- 1, Attached
- Water
- Well
- Sewer
- Septic System
- Year Built
- 1978
Rooms and Land
- MasterBedroom
- 11X13 1st Floor
- Bedroom2
- 9X13.5 1st Floor
- Bath
- 9X7 1st Floor
- Kitchen
- 13X22 1st Floor
- Laundry
- 13X9 1st Floor
- Living
- 13X18 1st Floor
- Other
- 5.5X6 1st Floor
- Basement
- Crawl Space
- Heating
- Electric, Wood, Wood/Pellet Furnace
- Acreage
- 1.21
- Lot Dimensions
- 200x265
- Exterior Materials
- Vinyl
Listing Video for 17232 E Second Street, Wellston MI 49689
Mortgage Calculator
Listing Broker
Listing Courtesy of Big River Properties
Office Address 5963 W. 10 1/2 Mile Road Po Box 116
Listing Agent Nancy Randall
Listings last updated: . Some properties that appear for sale on this web site may subsequently have been sold and may no longer be available.
Our Michigan real estate agents can answer all of your questions about 17232 E Second Street, Wellston MI 49689. Real Estate One, Max Broock Realtors, and J&J Realtors are part of the Real Estate One Family of Companies and dominate the Wellston, Michigan real estate market. To sell or buy a home in Wellston, Michigan, contact our real estate agents as we know the Wellston, Michigan real estate market better than anyone with over 100 years of experience in Wellston, Michigan real estate for sale.
The data relating to real estate for sale on this web site appears in part from the IDX programs of our Multiple Listing Services. Real Estate listings held by brokerage firms other than Real Estate One includes the name and address of the listing broker where available.
IDX information is provided exclusively for consumers personal, non-commercial use and may not be used for any purpose other than to identify prospective properties consumers may be interested in purchasing.
All information deemed materially reliable but not guaranteed. Interested parties are encouraged to verify all information. Copyright© 2017 MichRIC LLC, All rights reserved.


text:
About "Giddy Up!" by slaterock
Giddy Up!
Design by slaterock
For all you Cowboys and Cowgirls out there.
haha i like ur style
yee haw!
my fav of the new batch
sweet horse!!!!!!
5 buy
rollin rollin rollin!
love the cahracter $5
so clean!!!
nice! :D love this one also 5
Love it!
Awesome character!
love your drawing style.....so much...
love your drawing style.....so much...
Bloody hell, so far three for three. I'm waiting for the fourth. Beautiful, nutty, creative work. I'm a fan. Though apparently you don't need any more.
nice! 5$
Hot damn that is a fine illustration!
Whatever it is they slipped into your water supply, keep drinking your daily allowance of it. Amazing!
super style!!
Love the horse! Really like the style.
yes! 5$
Wow, awesome clean style !
I love cowboys and I love your style! Gorgeous line-work - wicked illustration!
superb! :)
lovely illo
eww~~in indonesian, it's :KEREN!!!
Sweet character!
so ridiculously awesome
Awesome style, I agree with FA
very cool!
lovely horse!!
great style


text: PoliticsPoland left uneasy as Crimea crisis continues Poland agrees with Ukraine's new government in that Russia should not dominate Eastern Europe once again. 18 Mar 2014 11:31 GMT | Politics, Europe, US & Canada, Poland, Russia The events in Crimea are making Poland anxious. It is placed between Ukraine to the southeast and the Russian enclave of Kaliningrad to the north. Polish resentment towards Russia goes back centuries. Al Jazeera's Rory Challands reports from Warsaw.Source: Al Jazeera


text:
Today @NCCapitol (6/11): House budget marches on; Senators focus on lower profile bills
Posted June 11, 2014
Raleigh, N.C. — Good morning and welcome to Today @NCCapitol for Wednesday, June 11. Here's what's going on at the legislature and around state government.
THE GOVERNOR: Gov. Pat McCrory is in Washington, D.C. Among the stops on his public schedule is a confab with Federal Communications Commission members. A McCrory spokesman says the governor will be talking about ways to improve digital learning with the feds.
THE HOUSE: The state House's calendar is dominated by budget action. Finance Committee members will review the $21 billion spending plan at 8:30 a.m. The Appropriations Committee will begin its review at 10 a.m. There are no House floor votes scheduled.
WRAL.com will carry the House Appropriations Committee live. Check the Video Central box on the homepage for a link.
BUDGET: The budget rolled out by House Speaker Thom Tillis and company looks little like the spending plan put forward by their colleagues in the Senate. Although there is a pay raise for teachers, it is not tied to surrendering career status – sometimes called tenure – rights and does not cut teaching assistants. Rather, it relies on a budgeted bump in funding from the state lottery to pay for raises.
Like their Senate colleagues, House budget writers propose moving the State Bureau of Investigation from an office controlled by the attorney general, currently Democrat Roy Cooper, to one controlled by the governor, currently Republican McCrory. However, unlike the Senate, the House leaves the crime lab under Cooper's purview.
House leaders also larded some pet policy into the budget, including a ban on tanning beds, requiring a new head of the state's Medicaid division to be confirmed by the legislature and a plan to sell Jennette's Pier in Nags Head.
In Medicaid, House leaders don't make any of the dramatic changes called for by the state Senate. Rather, the House sets aside funding to continue studying reform options.
When the Senate budget came out, McCrory took pains to say he had "concerns" about the spending plan. If we were to read the tea leaves, the governor appears more kindly disposed toward the House version of the budget.
"I will continue to support a budget plan that provides sustainable raises for teachers and state employees, protects teacher assistants, protects master's pay, provides career pathways for teachers and funds core services for the needy and disabled," McCrory said in a statement. "I'd like to thank Speaker Tillis and other members of House leadership for listening on these important issues. I look forward to working with the House and Senate to build on the strengths of both plans."
DENR budget boost a far cry from pre-recession funding DENR: If budget proposals from the governor and both chambers of the General Assembly are any indication, the state's environmental regulator will see a funding boost for the second straight year heading into July. But no matter what the final budget version shows when lawmakers emerge from their committees over the coming days, state funding for the Department of Environment and Natural Resources won't come close to what it's lost since 2008.
THE SENATE: With the House focused on the budget, the Senate calendar is dotted with items that haven't gotten a lot of attention thus far this session. The General Assembly posts a full legislative calendar daily. Here are the items @NCCapitol will be keeping an eye on.
Senate Education (10 a.m. | 544 LOB): Senators will take up a bill once against tinkering with the approval process for charter schools.
Senate Health Care (11 a.m. | 544 LOB): The committee takes up a bill that would allow the state to keep closer tabs on the distribution of prescribed medication.
Senate Transportation (11 a.m. | 1027 LB): Committee members look at bills that include a measure to allow for ramp meters, automated devices that control the flow of traffic on highway on-ramps.
Senate Finance (1 p.m. | 544 LOB): The committee takes up a bill "modernizing" the state's business courts, including a provision that would require complex business cases be appealed directly to the state Supreme Court rather than the the Court of Appeals.
Senate Session (3 p.m. | Senate Floor): Among the bills on the Senate calendar are measures requiring background checks for firefighters, expanding restrictions on sex offenders and allowing for the annual Possum Drop in Clay County.
COAL ASH: The Associated Press reports:
A federal judge says a lawsuit accusing Duke Energy coal ash pits of polluting a lake near Wilmington can move forward. The Southern Environmental Law Center filed a lawsuit last year on behalf of environmental groups, saying the toxic waste was polluting Sutton Lake and violating the federal Clean Water Act. Duke Energy sought to dismiss the case, saying the groups didn't have a role because a state environmental agency already took enforcement action.
Federal Judge Louise Flanagan said Monday the state's enforcement action dealt with groundwater violations, but Sutton Lake is a public waterway and subject to the provisions of the federal law.
NOTED: Sen. Jerry Tillman, R-Randolph, has filled a constitutional amendment that would do away with the state superintendent of public instruction and the State Board of Education in favor of an appointed secretary of education.
ALL'S FAIR: It wasn't quite a dunking booth, but enough urban lawmakers and tax reform advocates took aim Tuesday at a proposed tax loophole for county agricultural fairs to soak the idea on the House floor. The House voted 60-57 to defeat the bill, which would have exempted fairs from collecting sales tax on tickets for entertainment events.
CIRCLING THE RUNWAY: Lawmakers are hoping to dislodge a dispute over the fate of the Charlotte Douglas International Airport from a legal stalemate through a bill put on the legislative fast-track Tuesday. The measure, which cleared the Senate Finance Committee, makes more than a dozen small changes to a law the General Assembly passed last year to put the airport into the hands of a newly created commission, which has been embroiled in a lawsuit almost from the moment it passed the legislature.
PPP: The state House on Tuesday passed its own version of a bill to turn some of the marketing and job-recruitment functions of the Commerce Department over to a private nonprofit. Senators have already passed their own, different version of the bill.
ZEB: Applause rang out in the state Senate chamber on Tuesday as lawmakers honored the memory of former Sen. Zebulon "Zeb" Alley, a legislative stalwart and longtime lobbyist who died last July at age 84.
TORTS: A package of changes to state laws is rolling on without two controversial provisions. Senate Judiciary Committee members voted down a measure that would have granted manufacturers of pharmaceuticals – or virtually any product from car seats to cribs – immunity from lawsuits if their goods were reviewed and approved by any government agency, such as the U.S. Food and Drug Administration. However, they did add to the bill a provision that three-judge panels would hear challenges to the constitutionality of state laws.


text:
- Group:
- Member: Members
- Active Posts:
- 307 (0.07 per day)
- Most Active In:
- General Sonic Discussion (74 posts)
- Joined:
- 27-October 04
- Profile Views:
- 2829
- Last Active:
- Feb 26 2014 12:44 PM
- Currently:
- Offline
My Information
- Member Title:
- Here is a man who stood up.
- Age:
- 28 years old
- Birthday:
- January 31, 1989
- Gender:
- Male
Contact Information
- E-mail:
- Click here to e-mail me
- Website:
- http://
Previous Fields
- National Flag:
- us
Latest Visitors
28 Oct 2013 - 23:26
24 Dec 2012 - 18:24
The Fralin Boy
09 May 2012 - 17:11
20 Mar 2012 - 01:58
18 Feb 2012 - 22:31
Topics I've Started
Possible new pirate
04 February 2005 - 06:35 PM
Water texture hack for EC
30 January 2005 - 02:07 AMMakes the water in Emerald coast look a little better.
New Sonic game info
14 January 2005 - 01:12 AMAccording to this month's Nintendo Official Magazine UK:
QuoteSonic Team head, Yuji Naka, revealed two new Sonic the Hedgehog games for Nintendo in an exclusive interview with NOM in London at the end of last year.
"We are in development with a new GameCube Sonic game, which we hope to release before the end of 2005," Naka exclusively revealed to us. "Sonic Team is also currently making a Sonic game for the DS. We are taking our time to make sure the game makes good use of the DS's many new features." Double whammy!
We pressed for details and Naka revealed that the DS game will incorporate parts of the screen-rubbing Sonic tech-demo shown at E3 last year. Naka expects both titles to be playable at this year's E3 and, as always, we'll be there to see it all.
Pick up NOM UK next month for the fll interview, where Yuji Naka reveals his secret conversations with Shigeru Miyamoto about getting Sonic and Mario to appear in a game together. No, you are not dreaming.
Supersonic DX
07 January 2005 - 09:44 PMDemo of Supersonic Dx, mind you this was a bit rushed so it will not be as... prettyful and detailed to the extreme, however it will give a nice enviroment and has some pretty nice music and quality as well.
Also on there is a song update zip that needs to have the songs placed in system/sounddata/bgm
Music Update


text:
- {{matchup.date.fullday}}{{matchup.date.month + ' ' + matchup.date.day}}
Central Arkansas vs Louisiana Tech Recap - Bulldogs Win 48-42
Nick Isham threw for 318 yards to lead the Bulldogs over Central Arkansas 48-42 on Saturday in Week 2 action at Joe Aillet Stadium.
Bettors who backed the Bulldogs were disappointed, as they failed to cover the closing number of 17. Over-Under bettors saw the total score go OVER the closing total of 49.5.
Lennon Creer rushed for 177 yards, while Ray Holley added 49 yards in the win. Quinton Patton and Taulib Ikharo added 211 and 67 receiving yards respectively.
Terence Bobo rushed for 46 yards for Central Arkansas, while Anthony Blackmon added 31 yards. Nathan Dick threw for 372 yards for the Bears, while receivers Jesse Grandy and Isaiah Jackson had 148 and 65 yards respectively.
Louisiana Tech outgained Central Arkansas 542-445 yards in the game, while the battle of first downs was won 26-23 by the Bulldogs.
Louisiana Tech lost the time of possession battle 34:54/25:06, leaving their defense on the field more than they wanted.
Louisiana Tech looks to continue their winning ways next game with a battle against Houston. Central Arkansas will aim to get back on the winning track at Arkansas State.


text:
This site proudly serves members and residents of South Dakota.
Do you reside in another state? Click here to access the site for you home club.
This member number is associated with a different email address. Please contact support.
The membership number entered appears to be incorrect. Please check your entry.


text:
I was curious if anyone has been following the ARG for Nine Inch Nails new album, Year Zero. The album takes place 15 years in the future (2022), and it isn't too nice of a place and time to be living. Pretty much imagine if world and national events continue on their current course, and you've got an idea of what's going on. Anyway, there have been websites, found usb drives, phone numbers, emails, videos, spectrograph analysis of audio and video, Morse code laced into emails...all sorts of crazy things. As far as viral campaigns go, its pretty amazing.
The album finally leaked out this past week, and was posted up on NIN's website the next day for high quality listening. If you haven't heard it, check it out; it's very good.
edit: If you want more info, check out the Echoing The Sound forums, or the NIN Wiki.


text:
Rainbow Slaw Salad
By Other
This slaw is pretty on the plate AND on the taste buds.
- Prep Time:
Serves: 6
Cups of Fruits & Vegetables per Serving: 1
Ingredients1/4 wedge of red cabbage
1/4 wedge of white cabbage
1 golden yellow beet, optional
1 chioga beet, optional
1 watermelon daikon radish
1 stalk celery
1 large carrot
1/4 jicama
1 cucumber
1 green apple
1 zucchini
Lemon juice
Dressing of your choice (Use non-vinegar based dressings. Poppy seed dressing is recommended)
DirectionsCut up all vegetables and apple; combine in a large mixing bowl. Squeeze lemon juice over salad. Toss salad with dressing. Serve.
Nutritional Information
- Calories: 80
- Carbohydrates: 18g
- Total Fat: 0g
- Cholesterol: 0mg
- Saturated Fat: 0g
- Dietary Fiber: 6g
- % of Calories from Fat: 0%
- Sodium: 55 mg
- Protein: 3g
- Recipe Credit
Recipe courtesy of Regal Ware Worldwide
- Comments (0)
Make a Comment:
- 0 new comments
Showing 0 comments
No comments yet.


text:
MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- VIVUS, Inc. today announced that data on Qnexa(TM), an investigational new drug, will be presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley Day, PhD, vice president of clinical development at VIVUS, will present data from the company's two year long phase 3 obesity trials, and Dr. Timothy Garvey, MD, professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham, will present data from the year long phase 2 study in type 2 diabetics.
"I am pleased that Dr. Day and Dr. Garvey can share the results of the phase 3 obesity studies and phase 2 obesity studies with our colleagues in the medical and pharmaceutical community," stated Leland Wilson, president and chief executive officer of VIVUS. "We are actively pursuing a comprehensive presentation and publication strategy, and are excited by the opportunity to communicate these data at Obesity Society's annual meeting. We look forward to additional presentations in the future with the ultimate goal of publication in a top-tier medical journal."
Following are details about the upcoming presentations:
27th Annual Scientific Meeting of The Obesity Society, October 24-28, 2009, Marriott Wardman Park Hotel, in Washington, DC
Date and Time: Saturday, October 24, 2009, 1:00 PM EDT
Session: Preconference
Presentation: Pharmacotherapy Update
Chairs: Ken Fujioka, MD, Louis J. Aronne, MD, and Richard Pratley, MD
Presenter: Wesley W. Day, PhD
Date and Time: Sunday, October 25, 2009, 5:30 PM EDT
Session: Pharmacotherapy
Presentation Title: "One-Year Treatment with Low Dose VI-0521 in Type 2 Diabetes Demonstrates Sustained Weight Loss and Continuous Glycemic Benefit"
Presenter: W. Timothy Garvey, MD
About Qnexa
Qnexa (Q-NEX-uh) is a once-a-day, proprietary, oral, controlled-release formulation of low dose phentermine and topiramate, which is believed to address both appetite and satiety - the two main mechanisms that impact eating behavior - in one capsule. Qnexa, an investigational drug, is being developed to address weight loss. In phase 2 and 3 clinical data to date, Qnexa has demonstrated significant weight loss, glycemic control, and improvement in cardiovascular risk factors.
About VIVUS
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa(TM), has recently completed phase 3 clinical trials for the treatment of obesity. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on VIVUS' current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; reliance on sole source suppliers; limited sales and marketing efforts and dependence upon third parties; risks related to the development of innovative products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical studies discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2008 and periodic reports filed with the Securities and Exchange Commission.
SOURCE VIVUS, Inc.
CONTACT: VIVUS, Inc., Timothy E. Morris, Chief Financial Officer,+1-650-934-5200; Investor Relations: The Trout Group, Brian Korb,+1-646-378-2923; or Media Relations: Pure Communications, Inc., SherylSeapy, +1-949-608-0841
Web site: http://www.vivus.com/


text:
I was originally sceptical about this mouse having previously bought a trackball which was also meant to be more ergonomic and reduce carpal tunnel syndrome and repetitive strain injury. Having tried a trackball for three months it was actually making my arm and wrist ache more and I was desperate to find something that worked.
Having researched a lot before I bought, I could see the advantage of buying a mouse that keeps your hand in the "handshake" position because it is much more natural.
While it took a little bit of getting used to, it was quicker to get to grips with than converting to a trackball and within a week the pains that I was getting in my wrist and forearms had already started to disappear.
I have now been using this mouse for about 6 months and I can honestly say that I will never switch back to an old type of mouse.
I think the main difference between this and some of the other options out there is price. This is very reasonable compared to some of the ergonomic mice produced by well known brands like Logitech and unlike some of the Logitech mice I have used in the past this one does not disappoint.
There are two downsides that I have found through using this mouse.
Firstly, the scrolling button under your fingers is meant to perform the same function as a mouse wheel, but does not work very well and usually just results in performing the same function as a left click rather than scrolling or zooming.
Secondly while 3M have since brought out a wireless version of this mouse there wasn't one available at the time I bought mine and while I would have paid a little more for having a wireless mouse, I think that the wireless version is much more expensive. However, if like me you use a mouse all day then I would definitely recommend getting this one.


text:
I'm looking to dip my toe into the projector family of things and was wondering, does anyone own one of these Optoma H180X Projectors ?
Is it as good as I am reading about online ?
Seriously considering buying this tbh and £380.00 seems to be the going rate. .... price considering.


text:
Vennligst vent...
Prebz og Dennis PC
Marcus og Martinus PC
Black Friday
Test av norske nettbutikker
Cisco SPS2024 24-Port 10/100/1000 Gigabit SP Switch
Service Provider-Focused Metro Access Solution Suited for MTU/MDU Applications
• Cost-effective access or customer premises equipment (CPE) switch for Metro Ethernet deployments
• Comprehensive security features for robust multitenant separation
• Optimized for triple-play (VoIP, video, and data) services
• Service provider provisioning and management features
The Cisco® SPS service provider switches deliver cost-effective Metro Ethernet access solutions. These products are optimized for multitenant units (MTUs) and multidwelling units (MDUs) in which the service provider delivers triple-play (VoIP, video, and data) services to multiple businesses or homes in close proximity.
The Cisco SPS2024 24-Port 10/100/1000 Gigabit SP Switch is ideal for environments in which security and uptime are important. It offers 24 Gigabit copper ports and 2 shared Small Form-Factor Pluggable (SFP) modules for optional optical interfaces for connecting to the core network.
The Cisco SPS switches facilitate the delivery of multiple services over a Layer 2 network with support for Q-in-Q stacking. This feature allows customer VLANs to be kept separate across the service provider backbone. Also, for efficient delivery of multicast traffic (such as video) to multiple customers, these switches provide support for a variation of Multicast VLAN Registration (MVR).
Network security is a primary concern for service providers, and the SPS switches deliver a number of advanced features that alleviate this concern. Support for dynamic Address Resolution Protocol (ARP) inspection eliminates the man-in-the-middle attack. IP Source Guard prevents a subscriber (or malicious user) from using an IP address not assigned to them. DHCP Guard keeps rogue devices from behaving like Dynamic Host Configuration Protocol (DHCP) servers. Spanning Tree Protocol (STP) Root Guard prevents a rogue spanning tree device from advertising that it should be the root bridge, thereby having the spanning tree network compromised by an outside device. Unauthorized access to the network is protected through 802.1X port and multisession authentication and MAC filtering/port security. The 802.1X standard requires clients to authenticate themselves before the port will pass data for them. An additional security feature is access control lists (ACLs), which restrict network use to certain users, groups, or applications. The SPS switches also secure management traffic, with support for Secure Shell (SSH) Protocol, SSL, and Simple Network Management Protocol (SNMP) v3.
The management capabilities of the SPS switches include support for DHCP option 82, allowing for assignment of IP addresses to subscribers based on where they connect to the network. Management can be performed through a GUI or command-line interface (CLI). The switches also support SNMP for management from a network management station.
• Twenty-four 10/100/1000 switched RJ-45 ports that deliver up to 2000 Mbps of throughput per port
• Two shared mini Gigabit Interface Converter (mini-GBIC) slots for fiber and copper Gigabit Ethernet expansion
• 48-Gbps nonblocking, store-and-forward switching mechanism
• Simplified QoS management enabled by advanced queuing techniques using 802.1p, Differentiated Services (DiffServ), or type of service (ToS) traffic prioritization
• Configuration and monitoring from a console port with the CLI or from a standard web browser with WebView management
• Secure remote management of the switch via SSH and SSL secure channel network protocols
• 802.1Q-based VLANs, enabling segmentation of networks for improved performance and security
• Stacking Q-in-Q VLANs, allowing customer VLANs to transparently cross a service provider network and isolate traffic among customers
• Private VLAN Edge (PVE) for simplified network isolation of guest connections or autonomous networks
• Automatic configuration of VLANs across multiple switches through Generic VLAN Registration Protocol (GVRP) and Generic Attribute Registration Protocol (GARP)
• Automatic medium dependent interface (MDI) and MDI crossover (MDI-X) detection
Cabling type
Unshielded twisted pair (UTP) category 5 (CAT5) or better for 10BASE-T/100BASE-TX, UTP CAT5e or better for 1000BASE-T
Giga Link/Act, Giga Speed, Mini-GBIC Link/Act, Speed, System
Switching capacity
48 Gbps, nonblocking
Forwarding rate
35.71 Mpps wire-speed performance
Layer 2
MAC table size
Number of VLANs
256 active VLANs (4096 range)
HOL blocking
Head of Line (HOL) blocking prevention
Multicast VLAN Registration implementation, also known as Multicast TV VLAN
Web user interface
Built-in web UI for easy browser-based configuration (HTTP/HTTPS)
CLI interface
CLI support via console port or Telnet
SNMP versions 1, 2c, and 3, with support for traps
SNMP MIBs
RFC 1213 MIB-2, RFC 2863 Interface MIB, RFC 2665 Ether-like MIB, RFC 1493 Bridge MIB, RFC 2674 Extended Bridge MIB (P-bridge, Q-bridge), RFC 2819 Remote Monitoring (RMON) MIB (groups 1, 2, 3, and 9 only), RFC 2737 Entity MIB, RFC 2618 RADIUS Client MIB, RFC 1215 Traps
Embedded RMON software agent supports 4 RMON groups (history, statistics, alarms, and events) for enhanced traffic management, monitoring, and analysis
Firmware upgrade
CLI upgrade and web browser upgrade (HTTP) and Trivial File Transfer Protocol (TFTP)
Port mirroring
Traffic on a port can be mirrored to another port for analysis with a network analyzer or RMON probe
Other management
Access control
Access security
Link aggregation
Storm control
Broadcast, multicast, and unknown unicast
Spanning tree
IEEE 802.1D Spanning Tree, IEEE 802.1w Rapid Spanning Tree, IEEE 802.1s Multiple Spanning Tree, STP Root Guard
IGMP snooping
Internet Group Management Protocol (IGMP) (versions 1 and 2) snooping provides for fast client joins and leaves of multicast streams and limits bandwidth-intensive video traffic to only the requestors. Supports 256 multicast groups.
Priority levels
4 hardware queues
Priority queuing and weighted round robin (WRR)
Class of service
Per flow QoS
Rate limiting
802.3 10BASE-T Ethernet, 802.3u 100BASE-TX Fast Ethernet, 802.3ab 1000BASE-T Gigabit Ethernet, 802.3z Gigabit Ethernet, 802.3x Flow Control, 802.3ad LACP, 802.1D STP, 802.1Q/p VLAN, 802.1w Rapid STP, 802.1s Multiple STP, 802.1X Port Access Authentication
DimensionsW x H x D
16.93 x 1.75 x 13.78 in.(430 x 44.45 x 350 mm)
Unit weight
8.60 lb (3.9 kg)
Internal switching power
Power consumption
100-127V/2.0A, 200-240V/1.0A, 50-60 Hz, 33W
No fan
FCC Part 15 Class A, CE Class A, UL, cUL, CE Mark, CB
Operating temperature
32° to 104°F (0° to 40°C)
Storage temperature
-4° to 158°F (-20° to 70°C)
Operating humidity
10% to 90%
Storage humidity
10% to 95%
Package Contents
Minimum Requirements
Product Warranty
5-year limited hardware warranty with return to factory replacement and 90-day limited software warranty
Varer som er tilgjengelig på lager, sendes normalt innen 5 dager. Bildet kan avvike fra produktet. Vi tar forbehold mot trykkfeil og endringer av priser og spesifikasjoner uten varsel
Følg oss på Twitter
Følg oss på instagram


text:
Mac confirms Nugent liking
By Graeme Bailey
Last Updated: 01/01/70 1:00am
Steve McClaren has confirmed he would have 'no hesitation' in calling up David Nugent.
England manager Steve McClaren has confirmed he would have 'no hesitation' in calling up David Nugent.
The Preston striker has been tipped to earn a shock call-up, as McClaren prepares to name his next squad which will face Israel and Andorra in Euro 2008 qualifiers later this month.
With question marks lingering over Darren Bent's fitness - it is being suggested that Nugent could very well be promoted from the England Under 21 squad.
"Rooney, Andy Johnson, Defoe and Darren Bent are our four strikers, obviously Darren has had an injury and we hope he comes through. We hope he plays at the weekend, we will give him every opportunity," McClaren told Sky Sports News.
"I have had a look at Nugent and I would have no hesitation, through his performances in the Under 21s, to put him in the squad.
"He's got a lot of goals in the Championship, every season he does that. Internationally you look at the Under 21s and if he can score at that level, and he has done."


text:
At 2 a.m. this morning (May 26), a man was attacked at the corner of Bowser and Prescott in the neighborhood south of Highland Park. This was a different type of attack that previous ones reported and a different Oak Lawn neighborhood.
According to Fox News, someone jumped out of a red SUV, punched the victim in the eye, then jumped back in the car and sped off.
Here's the information police released:
Assault at 5000 Bowser Avenue
On May 26, 2016 at about 2 a.m., the victim was walking home from a bar in the 5000 block of Bowser Avenue when an unidentified suspect exited a red or maroon SUV and assaulted him causing injury to his eye and ankle. Throughout the attack the suspect did not say anything, nor did he attempt to take the victim's property. The suspect then re-entered the SUV and drove away.
The individual that suffered this attack so far has been unable to provide any additional information. It is early in the investigation and the detective will be canvassing the area for video and potential witnesses. Anyone with information regarding this offense is encouraged to contact Detective McKnight-Bell at (214) 671-3600.


text:
14 Karat Yellow Gold Solid Figaro Link Necklace - 20"
Item #: 515408 | Model #: FIG120-20 |
Price includes shipping
- $ 607 00 607.00
10% non-member fee may apply.Join now!
- Shipping
- Price includes shipping
- Enter ZIP Code for shipping options
- Estimated arrival
- Free Pickup
Delivery estimates, taxes, and fees are based on ZIP Code. Club Pickup orders are based on your club's current price and item availability on the day of payment.
About this itemThis 20" length figaro is finished in a high polished 3x1 alternating link. The link is solid 14k yellow gold and secures with a lobster lock.
Classically styled in high quality, a link necklace for all ages. Necklace measures 4.5mm in width and is finished with a bevelled edge which makes this piece very comfortable to wear.
- 14K Solid Yellow Gold
- 3 x 1 Alternating Figaro Link
- Polished Finish
- 4.5mm Width
- 20" Length
- Lobster Lock Closure
Assembled Country
Component Country
Member reviews & questions
Ask & Answer
Policies & plans
Shipping Information
Express - 1 to 2 business days
Some items require customization Click here for estimated delivery.
Warranty Information
This product is covered by the Sam's Club Member Satisfaction Guarantee.


text:
Oh no, your cart is empty. Add something awesome to it!
Each purchase supports an independent artist.
"...as fast as I'll slap his wife on the ass if she doesn't make me a steak, medium rare. Just the way I like it."
steak, chael-sonnen, ragreynolds
Medium Rare Long Sleeve T-Shirt
Cover art from 'Medium Rare: A Guide To Fine Dining & Perfect Timing'.
ragreynolds, steak, youtube, book, cover-art
Medium Rare Cover Art Long Sleeve T-Shirt
For sales, exclusive content, and more!
Already have an account?
Log in.
New here?
Create an account.


text:
INFO SOLUTIONS is Information Technology solution provider firm develops customized Software and specializes in state-of-the-art technologies and providing best solutions with the help of talented professionals.
INFO SOLUTIONS is a dynamic organization with a strong commitment towards providing innovative and cost-effective solutions, with the flexibility and adaptability to meet the required needs of our clients.
INFO SOLUTIONS have rich experience in developing customised software for multifarious applications in various business houses.


text:
Girls 3-pack Knit Burpcloths
Even the daintiest baby girl needs some after meal time coverage. Keep you and your little one clean and happy with these 100% cotton interlock girls' burpcloths.
Product Details
- 100% cotton interlock
- features embroidery art
- imported
- machine wash / tumble dry
Item #: g3_burpcloth_flower


text:
backup downloads don't start (and a suggestion)
Hello guys,
as I listed in the backupwordpress thread (http://wordpress.org/support/topic/plugin-update-with-wpremote), i think that is valid to report here too:
when I make a "download backup" in the wpremote site app, when the zip is done, and the default popup opens, the download dont start anymore.. I receive this page error:
You don't have permission to access /wp/wp-content/e4658d28c2-backups/site-com-manual-complete-2012-11-26-16-24-40.zip on this server.
Additionally, a 404 Not Found error was encountered while trying to use an ErrorDocument to handle the request.
one suggestion:
I noticed that the wpremote zip file created, after download, remains stored in the server. Would be great if the file was automatically deleted. Or, if it can't be removed, it could be listed in one special category of backups in the backups page (but in my case, some hosts have a storage limit and I can't store many versions of backup, so, would be nice if it was deleted)
- The topic 'backup downloads don't start (and a suggestion)' is closed to new replies.


text:
Beer Pong
- Beer Pong Adult drinking game for boys nights in or out
- Includes 12 plastic cups, two pong balls and plastic beer pong mat
- Game of accuracy and control - get ball into each other's glass
- Once you've succeeded, drink; not succeeded, drink. Simple!
- A brilliant addition for any night in. Beer not included (sorry)
More product info
How to play
Lay out the beer pong mat and place 2 sets of cups on the coloured spots (red cups on the red spots, blue cups on the blue spots). Fill the cup with your chosen drink to the fill line as marked on the cups and you are now ready to play. Comprising 2 teams, or 1 or 2 players, the aim of the game is to remove all of the opposing team's cups from the table whilst they try to defend them. The first team to remove all of the opposing team's cups from the table wins.
Using the 2 beer pong balls, the first team takes a shot trying to get the two ball into the opposing cups. Should the 2 balls be "sunk" into the cup, the defending must immediately remove and drink the "sunk" cups. Place the empty cups to the side and it's now the defending team's turn. For full rules please see the included leaflet.


text:
NAACP youths receive lesson from older generation
(Patrick D. Rosso/Boston.com/2012)
On a warm Sunday afternoon, youths from the Boston NAACP walked around Malcolm X Park trying to get their friends and neighbors to register to vote and become members of the group. But while many were out there to share stories with other young people and community members, they instead received lessons from the older generation playing basketball.
"I look at each generation and it's like they are trying to outdo the older generation," said Martin White, a 43-year-old Roxbury resident who said many times the younger kids are trying to act tougher and "badder." "That ain't the way to go. I don't want to see anyone living the life I lived."
The crowd of nearly 20 basketball players, who ranged in age from 25-50, shared their stories at the impromptu forum. Although there were no megaphones or banners, the stories told were bold enough to touch nearly everyone in the park that day.
"There are a lot of things that if we had everyone on the same page we could change," said Reggie Eason, 50, of Roxbury as he took a break from a game of pick-up basketball. "It's good seeing young people out here. We have to get people talking to each other."
The high school and college-age youths who eagerly listened in hailed from many of the same neighborhoods and housing developments that the men talked to them about. Many knew each other's cousins and friends and shared painful stories about their own hardships and triumphs.
"You guys [the NAACP youth] are examples. Even if they [other youth] aren't talking to you, they are watching you," said Anthony Perry, a 47-year-old Hyde Park resident. "When you look around at the funerals, you see who's left. There are still plenty of people left but you have to go out and grab life."
Michael Curry, the president of the Boston NAACP, was also present Sunday, talking with the basketball players, many of whom were old friends from school or the neighborhood.
"The reality is black men are dying early or going to jail and we need to step up," said Curry. "We grew up in some grimy situations and at some point we have to do something about it, because tomorrow we could catch a bullet. These kids need somebody to step up."
Curry continued, reinforcing the importance of the youth learning from the older generation, or as many called them "the old heads".
"You don't need to be a college graduate, all you have to do is have a story to tell," said Curry. "Y'all got to tell your stories. You have to show them what you've been through."
Although the conversation only lasted about 20-minutes, many walked away with a sense of understanding. Although some of the youth members of the Boston NAACP, aren't new to the streets of Boston, having someone with 40-plus years of experience tell them what that life is like, hit home for many.
"We just want to talk about the issues. There are a ton of issues but somebody has to speak up about them," said Herb Lozano, 23, a Dorchester resident and youth coordinator for the Boston NAACP. "The people of color are the majority in this city and I think it's important that the majority voice their opinion."
Although the Boston NAACP has been active in the city for over a 100-years, the group is trying to revamp itself, bringing in fresh blood and more of the city's youth.
"We're really just trying to get more youth involved," said Janel Cambbell, 17, a Roxbury resident and nominated president of the NAACP's Youth Council. "We need to get the younger crowd involved so they know where they are and what's going on. We need to get the kids off the street and guide them."
With the increase in attention to the youth the Boston NAACP is working to form its first Youth Council, that will help guide initiatives targeted towards youth and provide a younger voice for the organization, all while trying to develop the next generation.
"We want to point them in the right direction," said Lozano. "They want to go to school, be in their community and be safe and we want to provide them that place."
Email Patrick D. Rosso, email@example.com. Follow him @PDRosso, or friend him on Facebook.


text:
|Page (1) of 1 - 05/28/14
|email article
|print page
Gaia Town Is a 3D Environmental Education Game
GUATEMALA CITY, May 28, 2014 /PRNewswire/ --The movement to become more environmentally responsible and create a sustainable society has taken root all over the world. Most experts agree that this will be a gradual process with future generations becoming more accountable for this change.
Photo - http://photos.prnewswire.com/prnh/20140528/91628
Photo - http://photos.prnewswire.com/prnh/20140528/91627
Thus education and involvement of today's youth is a critical component for a sustainable future. Could there be a better way to engage children than through a new video game?
Probably not. That's the strategy behind Gaia Town (www.gaiatown.com), an environmental education game for children. Gaia Town is being produced by Mas Digital, a Guatemalan gaming company.
"Gaia Town is a game in which you help our planet," said Antonio Carias, COO of Mas Digital.
"This environmental game educates through short lessons and reinforces through game play the importance of things like recycling, reducing carbon emissions, fire safety, organic food sources, energy solutions and more."
The first step in playing the game is creating a personalized town. Gaia Town then guides each player through different activities like picking up trash, recycling, harvesting crops and other unique pursuits that will determine the course of the town.
Each town can be viewed in rotating 3D, allowing players to check every building, street and angle. The goal is to increase the size of the town but in a sustainable way.
With complex game strategies, colorful and engaging graphics, and sophisticated functionality, this educational game requires many hours of work as well as intricate, multi-functional software. Carias estimates that $200,000 will be needed to fund the project.
He has launched a Kickstarter campaign, which can be viewed at www.kickstarter.com/projects/933524150/gaiatown-the-fun-game-to-save-the-planet. Donations of any amount are welcome.
The goal of Carias's Kickstarter project is to be able to release Gaia Town in September 2014. The funds will support the work needed to finish the game and publish on iTunes and Google Play. Carias would also like to expand the story, create new mini-games, add more avatars, broaden the city catalog, enhance the graphics, add other languages and so much more!
With your help, we can raise a generation of kids that understands how our planet works, realizes the challenges it is facing, and is prepared to create a better future.
Depending on their donation levels, backers can receive copies of the game, the Gaia Town soundtrack, their own avatar in the game and other perks.
For further information, visit www.kickstarter.com/projects/933524150/gaiatown-the-fun-game-to-save-the-planet; the Gaia Town website, www.gaiatown.com; or the Gaia Town Facebook page, www.facebook.com/pages/Gaia-Town/445242475590338?ref=hl.
Antonio Carias
SOURCE Mas Digital
Copyright 2014 PR Newswire. All Rights Reserved
Page: 1
Related Keywords:Science, Environmental Technology, Game Technology, Green Technology, Children, Other,


text:
Forum Replies Created
January 7, 2013 at 11:30 pm in reply to: Vertical Nav Bar #10288January 7, 2013 at 11:26 pm in reply to: Messy unformatted text output #10286
Please do not post same post in more than forum. I apologize but this is posting this message twice, probably because I merge the two into one?
January 7, 2013 at 11:25 pm in reply to: Messy unformatted text output #10283January 7, 2013 at 11:22 pm in reply to: Clickable header #10281January 7, 2013 at 11:21 pm in reply to: Adding code to the head of specific pages. #10280
This is actually a new feature of Genesis 1.9. Just fill out the user Google Plus information and it will do it for you.
January 7, 2013 at 11:18 pm in reply to: Using custom field and category to populate blog page #10277
Jen's post is accurate and a nice shortcut. You will need to create a page_blog.php and place that in your child theme. The current blog page template that is packaged in Genesis by default will not accomplish what you want. Another option would be to do this:
add_action( 'genesis_before_loop', 'child_custom_introduction', 25 );
* Add introduction content to page_blog.php template
function child_custom_introduction() {
if ( is_page_template( 'page_blog.php' ) ) {
global $post;
echo apply_filters( 'the_content', $post->post_content );
Also see how to use the query_args Easter Egg here and here.
January 7, 2013 at 11:05 pm in reply to: Messy unformatted text output #10276
I am assuming that the home page is being produced by a widget of some sort with content limit?? If this is the case, to add formatting by following this tutorial. For more information, please read Nick's Formating Explanations.
January 7, 2013 at 11:02 pm in reply to: Genensis 1.9 Upgrade Problems #10275
Ok, this needs to be customized properly now in Genesis 1.9 instead of using the Grid Loop. The updated Grid Loop now takes the original WP Query and does not add to it fixing a couple bugs from Genesis 1.8.
To fix this, you need to follow the instructions here: http://www.billerickson.net/customize-the-wordpress-query/
So, something like this:
add_action( 'pre_get_posts', 'wps_limit_loop_to_cat' );
* Limit Grid Loop to a Specific Category on a Specific Page
* @author Bill Erickson
* @author Travis Smith
* @link http://www.billerickson.net/customize-the-wordpress-query/
* @param object $query data
function wps_limit_loop_to_cat( $query ) {
// To Limit it on a page, change $post_id
if( $query->is_main_query() && $query->is_home() ) {
$query->set( 'cat', '25' );
add_action( 'pre_get_posts', 'wps_limit_loop_to_cat' );
* Limit Grid Loop to a Specific Category on a Specific Page
* @author Bill Erickson
* @author Travis Smith
* @link http://www.billerickson.net/customize-the-wordpress-query/
* @param object $query data
function wps_limit_loop_to_cat( $query ) {
// To Limit it on a page, change $post_id
if( $query->is_main_query() && $query->is_page( $post_id ) ) {
$query->set( 'category_name', 'parent-category-iii' );
January 7, 2013 at 10:53 pm in reply to: How to set the preferred category in breadcrumbs?? #10274
You need to install the sCategory Permalink plugin. Please let me know if it doesn't work. However, there is built-in support in the Breadcrumbs function/class for you to accomplish this with this plugin.
January 7, 2013 at 10:50 pm in reply to: WordPress 3.5 issues: Links, images and text feature #10273
This appears to be a WordPress 3.5 issue and could be related to how WP 3.5 redid their attachments and media UX. If you could, please record a Screenr on the process of what you are describing so we can better help you.
January 7, 2013 at 10:46 pm in reply to: Using Custom Post Types in the widgets area #10272
I am not sure I understand what you are asking? The Genesis Featured Widget Amplified enables you to accomplish the use of custom post types in widget areas. If you are asking for a custom approach then I recommend using the template hierarchy from WordPress. Or, if you do not mind, can you please elaborate a bit more on what you are trying to accomplish?
January 7, 2013 at 10:38 pm in reply to: Support ticket help please #10269
I apologize for the help ticket issues. Can you please create a new topic with your issue if your help ticket did not help?
January 7, 2013 at 10:36 pm in reply to: What happened to Title options in 1.9? #10268
If your theme supports a custom header, then this option is obsolete. Genesis 1.9 clears this up to force people to do it correctly.
January 4, 2013 at 2:02 pm in reply to: Tabs Plugin Code alteration to add more than one post #9554
This will work: https://gist.github.com/4455461
December 28, 2012 at 3:23 pm in reply to: A two colour Site Title #8006
I would recommend the first approach. The site that I did this on has changed to an image logo since the launch of the site not worrying about the SEO of their site name.
So here's basically what I did:
add_filter( 'genesis_seo_title', 'wps_seo_title', 10, 3 );
* Modify the Genesis SEO Title.
* @param string $title Default HTML title output.
* @param string $inside HTML blog name output.
* @param string $wrap h1 or p based on settings.
* @return string Modified HTML title output.
function wps_seo_title( $title, $inside, $wrap ) {
return sprintf( '
%s%s
', 'text for color 1', 'text for color 2' );


text:
7525 O'Connor Drive, Hale 48739
See more homes for sale in Hale, MI
Woods and Water on LOON LAKE. YOU CAN HAVE IT ALL. 3 BEDROOM YEAR ROUND HOME IN THE WOODS W/LIVING ROOM AND FAMILY ROOM, ATTACHED GARAGE, DECK, FIRE PIT, LARGE LOT. DEER AND WILDLIFE AND PRIVATE WATERFRONT DOCK AND SANDY BEACH. TWO PIECES OF PROPERTY, PRIVATELY OWNED, 12X210 ON SANDY BEACH WITH SEAWALL AND DOCK. HOUSE ON LARGE WOODED LOT. WOODS AND WATER YET CHEAPER TAXES. MOVE RIGHT IN! your 3 bedroom yr round house in the woods for deer and wildlife, bonfires,, lots of parking etc, yet just 50 ft across the trail to your privately owned not shared beach front with sea wall and dock,,,this way you have it all without the higher home on the lake taxes,, and lots of room without being right next to other houses on the lake, you must really see this one, lots of wooded privacy in this 3 br home then your own piece of land with sea wall and dock to park your boa, t swim at a nice sand beach and enjoy!! NOT SHARED you own and pay taxes on this small piece of Heaven In Hale Call today!
Property Information
- Status
- Active
- Address
- 7525 O'Connor Drive
- City
- Hale
- Zip
- 48739
- County
- Iosco
- Township
- Plainfield
- Possession
- At Closing
- Zoning
- Residential
- Listing Date
- 05/21/2013
- Total Finished SqFt
- 1,300
- Above Grade SqFt
- 1,300
- Garage Desc.
- Attached
- Waterview
- Waterfront
- Waterfront Desc
- All Sports, Inland Lake, Water View
- Waterfrontage
- 12.0
- Body of Water
- Loon Lake
- Water
- Private Well
- Sewer
- Private Septic
- Year Built
- 1947
- Home Style
- Ranch
Rooms and Land
- MasterBedroom
- Kitchen
- Living
- Basement
- Crawl Space
- Cooling
- Forced Air, Propane, Space Heater
- Heating
- Forced Air, Propane, Space Heater
- Acreage
- 0.66
- Lot Dimensions
- 92 x 290+ 12 x210
- Appliances
- Oven/Range, Refrigerator
- Fireplace Desc.
- None
- Interior Features
- Breakfast Nook, Den/Study, Great Room, Mud Room, Paneling
- Exterior Materials
- Vinyl
- Exterior Features
- Covered Porch, Deck, Patio, Porch
Listing Video for 7525 O'Connor Drive, Hale MI 48739
Mortgage Calculator
Listing Broker
Listing Courtesy of Carole Wilson Real Estate
Office Address 3221 N M-65
Listings last updated: . Some properties that appear for sale on this web site may subsequently have been sold and may no longer be available.
Our Michigan real estate agents can answer all of your questions about 7525 O'Connor Drive, Hale MI 48739. Real Estate One, Max Broock Realtors, and J&J Realtors are part of the Real Estate One Family of Companies and dominate the Hale, Michigan real estate market. To sell or buy a home in Hale, Michigan, contact our real estate agents as we know the Hale, Michigan real estate market better than anyone with over 100 years of experience in Hale, Michigan real estate for sale.
The data relating to real estate for sale on this web site appears in part from the IDX programs of our Multiple Listing Services. Real Estate listings held by brokerage firms other than Real Estate One includes the name and address of the listing broker where available.
IDX information is provided exclusively for consumers personal, non-commercial use and may not be used for any purpose other than to identify prospective properties consumers may be interested in purchasing.
Nothern Great Lakes REALTORS® MLS. All rights reserved.